Detalhe da pesquisa
1.
Novel regenerative drug, SPG302 promotes functional recovery of diaphragm muscle activity after cervical spinal cord injury.
J Physiol
; 601(12): 2513-2532, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815402
2.
Detection of perillyl alcohol and its metabolite perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative case.
J Neurosurg Case Lessons
; 4(8)2022 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36088606
3.
Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma.
Neurooncol Adv
; 3(1): vdab005, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33604574
4.
SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer's Disease.
Neurotherapeutics
; 18(4): 2468-2483, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34738197
5.
A Small Molecule Spinogenic Compound Enhances Functional Outcome and Dendritic Spine Plasticity in a Rat Model of Traumatic Brain Injury.
J Neurotrauma
; 36(4): 589-600, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30014757
6.
Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine CX516 in elderly participants with mild cognitive impairment: a progress report.
J Mol Neurosci
; 19(1-2): 197-200, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12212780
7.
Response to: The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury.
Trials
; 10: 110; author reply 111, 2009 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-19958522